- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Andrew D. Seidman, MD | Authors
Articles
Dr. Andrew D. Seidman on the Lack of a Biomarker in Certain Breast Cancers
March 01, 2016
Video
Seidman says currently there is not a HER2 histochemical test for gene amplification or signatures to best select patients for either CDK46 or MTOR inhibitor, as well for PI3 kinase inhibition.
Dr. Andrew D. Seidman on Targeted Treatments in Breast Cancer
December 22, 2015
Video
​Andrew D. Seidman, MD, attending physician, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, discusses the shift paradigm of breast cancer treatment and the development of targeted agents that disrupt certain pathways.
Surgery and Radiotherapy for Patients With Breast Cancer
August 29, 2013
Video
Andrew D. Seidman, MD, from Memorial Sloan-Kettering Cancer Center, discusses breast cancer treatment with surgery and radiotherapy.
Using Paclitaxel Schedules as Adjuvant Therapy for Breast Cancer
June 06, 2013
Video
Andrew D. Seidman, MD, comments on the findings of the phase III S0221 trial, which compared two schedules of paclitaxel as adjuvant therapy for breast cancer.